PT966424E - Aminobenzofenonas como inibidores da interleucina e da fnt - Google Patents
Aminobenzofenonas como inibidores da interleucina e da fntInfo
- Publication number
- PT966424E PT966424E PT98900270T PT98900270T PT966424E PT 966424 E PT966424 E PT 966424E PT 98900270 T PT98900270 T PT 98900270T PT 98900270 T PT98900270 T PT 98900270T PT 966424 E PT966424 E PT 966424E
- Authority
- PT
- Portugal
- Prior art keywords
- alkyl
- content
- carbamoyl
- alkoxycarbonyl
- trifluoromethyl
- Prior art date
Links
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 title 1
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 title 1
- -1 hydroxy, mercapto Chemical group 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 201000005671 spondyloarthropathy Diseases 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9701453.4A GB9701453D0 (en) | 1997-01-24 | 1997-01-24 | Aminobenzophenones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT966424E true PT966424E (pt) | 2004-09-30 |
Family
ID=10806523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98900270T PT966424E (pt) | 1997-01-24 | 1998-01-08 | Aminobenzofenonas como inibidores da interleucina e da fnt |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6313174B1 (enExample) |
| EP (1) | EP0966424B1 (enExample) |
| JP (1) | JP4250204B2 (enExample) |
| KR (1) | KR100544046B1 (enExample) |
| CN (1) | CN1188388C (enExample) |
| AT (1) | ATE269844T1 (enExample) |
| AU (1) | AU733561B2 (enExample) |
| CA (1) | CA2278798C (enExample) |
| DE (1) | DE69824705T2 (enExample) |
| DK (1) | DK0966424T3 (enExample) |
| ES (1) | ES2223116T3 (enExample) |
| GB (1) | GB9701453D0 (enExample) |
| HU (1) | HUP0000678A3 (enExample) |
| NZ (1) | NZ336754A (enExample) |
| PL (1) | PL334806A1 (enExample) |
| PT (1) | PT966424E (enExample) |
| RO (1) | RO120195B1 (enExample) |
| RU (1) | RU2200153C2 (enExample) |
| WO (1) | WO1998032730A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003505362A (ja) * | 1999-07-16 | 2003-02-12 | レオ・ファーマ・アクティーゼルスカブ | ＩＬ−１βおよびＴＮＦ−αの抑制剤としてのアミノベンゾフェノン |
| DK1210320T3 (da) * | 1999-07-16 | 2005-01-31 | Leo Pharma As | Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa |
| US6897236B1 (en) | 1999-07-16 | 2005-05-24 | Leo Pharmaceutical Products, Ltd. | Aminobenzophenones as inhibitors of IL-1β and TNF-α |
| US6750253B1 (en) | 1999-07-16 | 2004-06-15 | Leo Pharmaceutical Products Ltd. A/S | Aminobenzophenones as inhibitors of il-1β and tnf-α |
| EP1202954B1 (en) * | 1999-07-16 | 2003-10-01 | Leo Pharma A/S | Novel aminobenzophenones |
| AU768816B2 (en) * | 1999-07-16 | 2004-01-08 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha |
| AU776395B2 (en) * | 1999-12-06 | 2004-09-09 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha |
| EP1250332A1 (en) * | 1999-12-17 | 2002-10-23 | Abbott Laboratories | Inhibitors of interleukin 5 gene expression |
| JP2003519143A (ja) * | 1999-12-28 | 2003-06-17 | ファーマコピーア，インコーポレーティッド | ピリミジン及びトリアジン系キナーゼ阻害剤 |
| CA2408727A1 (en) * | 2000-05-22 | 2001-11-29 | Leo Pharma A/S | Benzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| US20020165286A1 (en) * | 2000-12-08 | 2002-11-07 | Hanne Hedeman | Dermal anti-inflammatory composition |
| SE0100569D0 (sv) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | New compounds |
| GB0107368D0 (en) * | 2001-03-23 | 2001-05-16 | Novartis Ag | Organic compounds |
| AU2002338286A1 (en) * | 2001-04-10 | 2002-10-28 | Leo Pharma A/S | Novel aminophenyl ketone derivatives |
| MXPA04001912A (es) * | 2001-08-28 | 2004-07-23 | Leo Pharma As | Aminobenzofenonas novedosas. |
| CN1753861A (zh) * | 2002-12-20 | 2006-03-29 | 利奥制药有限公司 | 新颖的氨基二苯酮化合物 |
| WO2005009940A1 (en) * | 2003-07-24 | 2005-02-03 | Leo Pharma A/S | Novel aminobenzophenone compounds |
| DK1828148T3 (da) * | 2004-12-13 | 2010-05-17 | Leo Pharma As | Triazolsubstituerede aminobenzophenonforbindelser |
| DE102005022020A1 (de) * | 2005-05-12 | 2006-11-23 | Merckle Gmbh | Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten |
| KR101057546B1 (ko) * | 2007-06-05 | 2011-08-17 | 주식회사 엘지화학 | 광학 이방성 화합물 및 이를 포함하는 수지 조성물 |
| EP2206534A1 (de) | 2008-10-09 | 2010-07-14 | c-a-i-r biosciences GmbH | Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten |
| WO2012167133A2 (en) * | 2011-06-01 | 2012-12-06 | The Regents Of The University Of California | Inhibitors of anandamide transport and their therapeutic uses |
| MX354772B (es) | 2011-08-19 | 2018-03-21 | Univ California | Inhibidores de la amida de acidos grasos (faah) restringidos perifericamente por bifenil metasustituido. |
| EP3988540A1 (en) | 2014-04-07 | 2022-04-27 | The Regents of the University of California | Inhibitors of fatty acid amide hydrolase (faah) enzyme with improved oral bioavailability and their use as medicaments |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1535401A (en) * | 1977-07-28 | 1978-12-13 | Holliday & Co Ltd L | Nitrodiphenylamine carboxylic acid disperse dyes |
| SU790620A1 (ru) * | 1979-06-01 | 1981-07-30 | Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского | Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ |
| JPH0776303B2 (ja) * | 1986-11-21 | 1995-08-16 | 株式会社リコー | 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料 |
-
1997
- 1997-01-24 GB GBGB9701453.4A patent/GB9701453D0/en active Pending
-
1998
- 1998-01-08 EP EP98900270A patent/EP0966424B1/en not_active Expired - Lifetime
- 1998-01-08 DK DK98900270T patent/DK0966424T3/da active
- 1998-01-08 CN CNB988028301A patent/CN1188388C/zh not_active Expired - Fee Related
- 1998-01-08 RO RO99-00839A patent/RO120195B1/ro unknown
- 1998-01-08 ES ES98900270T patent/ES2223116T3/es not_active Expired - Lifetime
- 1998-01-08 DE DE69824705T patent/DE69824705T2/de not_active Expired - Lifetime
- 1998-01-08 AT AT98900270T patent/ATE269844T1/de active
- 1998-01-08 HU HU0000678A patent/HUP0000678A3/hu unknown
- 1998-01-08 US US09/341,923 patent/US6313174B1/en not_active Expired - Fee Related
- 1998-01-08 AU AU54781/98A patent/AU733561B2/en not_active Ceased
- 1998-01-08 PT PT98900270T patent/PT966424E/pt unknown
- 1998-01-08 RU RU99118221/04A patent/RU2200153C2/ru not_active IP Right Cessation
- 1998-01-08 KR KR1019997006672A patent/KR100544046B1/ko not_active Expired - Fee Related
- 1998-01-08 JP JP53149998A patent/JP4250204B2/ja not_active Expired - Fee Related
- 1998-01-08 WO PCT/DK1998/000008 patent/WO1998032730A1/en not_active Ceased
- 1998-01-08 NZ NZ336754A patent/NZ336754A/xx not_active IP Right Cessation
- 1998-01-08 CA CA002278798A patent/CA2278798C/en not_active Expired - Fee Related
- 1998-01-08 PL PL98334806A patent/PL334806A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0966424T3 (da) | 2004-11-01 |
| ES2223116T3 (es) | 2005-02-16 |
| US6313174B1 (en) | 2001-11-06 |
| JP4250204B2 (ja) | 2009-04-08 |
| DE69824705T2 (de) | 2005-07-07 |
| RO120195B1 (ro) | 2005-10-28 |
| AU5478198A (en) | 1998-08-18 |
| NZ336754A (en) | 2001-03-30 |
| KR100544046B1 (ko) | 2006-01-23 |
| CN1188388C (zh) | 2005-02-09 |
| HUP0000678A2 (hu) | 2001-10-28 |
| CN1248966A (zh) | 2000-03-29 |
| EP0966424A1 (en) | 1999-12-29 |
| ATE269844T1 (de) | 2004-07-15 |
| JP2001511771A (ja) | 2001-08-14 |
| WO1998032730A1 (en) | 1998-07-30 |
| CA2278798A1 (en) | 1998-07-30 |
| HUP0000678A3 (en) | 2001-11-28 |
| KR20000070437A (ko) | 2000-11-25 |
| EP0966424B1 (en) | 2004-06-23 |
| RU2200153C2 (ru) | 2003-03-10 |
| CA2278798C (en) | 2007-07-03 |
| GB9701453D0 (en) | 1997-03-12 |
| PL334806A1 (en) | 2000-03-13 |
| AU733561B2 (en) | 2001-05-17 |
| HK1025306A1 (en) | 2000-11-10 |
| DE69824705D1 (de) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT966424E (pt) | Aminobenzofenonas como inibidores da interleucina e da fnt | |
| MY158162A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
| MXPA05013075A (es) | Inhibidores de p-38 basados en heterociclo de 5 miembros. | |
| DE602004019542D1 (de) | Proteasome inhibitoren und deren verwendung | |
| ATE420644T1 (de) | Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1) | |
| MY149960A (en) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases | |
| MXPA05013224A (es) | Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas. | |
| MXPA05005223A (es) | Diaminotriazoles utiles como inhibidores de proteinas cinasas. | |
| CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
| PL1699800T3 (pl) | Bicykliczne heterocykliczne inhibitory kinazy p-38 | |
| DK1660507T3 (da) | Proteasominibitorer og metoder til anvendelse heraf | |
| NO20071534L (no) | Behandling av inflammatoriske forstyrrelser og smerte | |
| NO20060518L (no) | Pyrimidiner nyttige som modulatorer av spenningsstyrte ionekanaler | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| DE69723863D1 (de) | Chinoline und deren therapeutische verwendung | |
| DK1758860T3 (da) | Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande | |
| MXPA02011858A (es) | Inhibidores de adhesion de celula mediada por alfabeta2. | |
| TW200503722A (en) | Substituted 7-aza-quinazoline compounds | |
| UA94054C2 (en) | Nitrocatechol derivatives as comt inhibitors | |
| DE602004010186D1 (de) | Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2 | |
| PT1751138E (pt) | Derivados de indol-2-ona para o tratamento de desordens nervosas centrais, desordens gastrointestinais e desordens cardiovasculares. | |
| TNSN05307A1 (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
| HK10797774A1 (en) | Aryl ureas as kinase inhibitors |